Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Lévesque

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 12, 2018
An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivativesPatrick Caron, Véronique Turcotte, Eric Lévesque, et al.
British Journal of Cancer|February 13, 2020
Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progressionEric P Allain, Michèle Rouleau, Eric Lévesque, et al.
Drug Metabolism Reviews|October 28, 2009
UGT genomic diversity: beyond gene duplicationChantal Guillemette, Eric Lévesque, Mario Harvey, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 24, 2012
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipientsIsabelle Laverdière, Patrick Caron, Félix Couture, et al.
Human Mutation|July 3, 2009
Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphismVincent Ménard, Olivier Eap, Mario Harvey, et al.
Analytical Chemistry|November 19, 2011
Liquid chromatography-coupled tandem mass spectrometry based assay to evaluate inosine-5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells from stem cell transplant recipientsIsabelle Laverdière, Patrick Caron, Félix Couture, et al.
Hepatology (Baltimore, Md.)|December 26, 2006
Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locusEric Lévesque, Hugo Girard, Kim Journault, et al.
Pharmacogenomics|July 4, 2008
Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteersEric Lévesque, Marie-Odile Benoit-Biancamano, Robert Delage, et al.
Pharmacogenetics and Genomics|November 16, 2007
Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activityHugo Girard, Eric Lévesque, Judith Bellemare, et al.
Pharmacogenetics and Genomics|September 2, 2011
Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variantsVincent Ménard, Olivier Eap, Joannie Roberge, et al.
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 12, 2018
An LC-MS/MS method for quantification of abiraterone, its active metabolites D(4)-abiraterone (D4A) and 5α-abiraterone, and their inactive glucuronide derivativesPatrick Caron, Véronique Turcotte, Eric Lévesque, et al.
British Journal of Cancer|February 13, 2020
Emerging roles for UDP-glucuronosyltransferases in drug resistance and cancer progressionEric P Allain, Michèle Rouleau, Eric Lévesque, et al.
Drug Metabolism Reviews|October 28, 2009
UGT genomic diversity: beyond gene duplicationChantal Guillemette, Eric Lévesque, Mario Harvey, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 24, 2012
A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for monitoring drug exposure in hematopoietic stem cell transplant recipientsIsabelle Laverdière, Patrick Caron, Félix Couture, et al.
Human Mutation|July 3, 2009
Copy-number variations (CNVs) of the human sex steroid metabolizing genes UGT2B17 and UGT2B28 and their associations with a UGT2B15 functional polymorphismVincent Ménard, Olivier Eap, Mario Harvey, et al.
Analytical Chemistry|November 19, 2011
Liquid chromatography-coupled tandem mass spectrometry based assay to evaluate inosine-5'-monophosphate dehydrogenase activity in peripheral blood mononuclear cells from stem cell transplant recipientsIsabelle Laverdière, Patrick Caron, Félix Couture, et al.
Hepatology (Baltimore, Md.)|December 26, 2006
Regulation of the UGT1A1 bilirubin-conjugating pathway: role of a new splicing event at the UGT1A locusEric Lévesque, Hugo Girard, Kim Journault, et al.
Pharmacogenomics|July 4, 2008
Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteersEric Lévesque, Marie-Odile Benoit-Biancamano, Robert Delage, et al.
Pharmacogenetics and Genomics|November 16, 2007
Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activityHugo Girard, Eric Lévesque, Judith Bellemare, et al.
Pharmacogenetics and Genomics|September 2, 2011
Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variantsVincent Ménard, Olivier Eap, Joannie Roberge, et al.
Pageof 4